NasdaqCM - Nasdaq Real Time Price USD
Cellectar Biosciences, Inc. (CLRB)
0.2640
+0.0085
+(3.33%)
At close: 4:00:01 PM EDT
0.2611
-0.00
(-1.10%)
After hours: 4:53:15 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 4 |
| Avg. Estimate | -0.13 | -0.13 | -0.54 | -0.8 |
| Low Estimate | -0.13 | -0.14 | -0.55 | -1.31 |
| High Estimate | -0.13 | -0.12 | -0.52 | -0.48 |
| Year Ago EPS | -0.03 | -0.37 | -1.22 | -0.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 4 |
| Avg. Estimate | -- | -- | -- | 31.1M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 124.4M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.27 | -0.37 | -0.35 | -0.16 |
| EPS Actual | -0.03 | -0.37 | -0.01 | -0.14 |
| Difference | 0.24 | 0 | 0.34 | 0.02 |
| Surprise % | 88.89% | 0.89% | 97.16% | 14.28% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.13 | -0.54 | -0.8 |
| 7 Days Ago | -0.15 | -0.16 | -0.64 | -0.85 |
| 30 Days Ago | -0.15 | -0.16 | -0.64 | -0.85 |
| 60 Days Ago | -0.15 | -0.16 | -0.64 | -0.85 |
| 90 Days Ago | -0.18 | -0.2 | -0.68 | -0.98 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 2 | 2 |
| Up Last 30 Days | 2 | 2 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CLRB | -333.33% | 64.86% | 56.15% | -49.53% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Downgrade | Maxim Group: Buy to Hold | 5/14/2025 |
| Downgrade | Oppenheimer: Outperform to Perform | 12/11/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/19/2024 |
| Maintains | Roth MKM: Buy to Buy | 3/28/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 3/28/2024 |
| Reiterates | Roth MKM: Buy to Buy | 3/4/2024 |
Related Tickers
ASMB Assembly Biosciences, Inc.
14.47
+4.86%
HLVX HilleVax, Inc.
2.0200
+3.59%
SPRO Spero Therapeutics, Inc.
0.6802
-1.26%
BOLT Bolt Biotherapeutics, Inc.
0.3297
+0.61%
CRGX CARGO Therapeutics, Inc.
4.1000
+0.24%
IPSC Century Therapeutics, Inc.
0.6000
+8.24%
RPTX Repare Therapeutics Inc.
1.3700
-0.72%
PMVP PMV Pharmaceuticals, Inc.
0.9308
+6.50%
SEER Seer, Inc.
2.0900
+0.97%
GLTO Galecto, Inc.
3.0600
-0.33%